<DOC>
	<DOCNO>NCT02477657</DOCNO>
	<brief_summary>Malignant ascites lead significant morbidity patient terminal cancer . Paracentesis provide relief , repeat hospital visit , pain , short duration relief paracentesis detrimental quality life ( QOL ) . Two device available alternative paracentesis . The impact either device QOL fully explore . A pilot nonrandomized trial measure palliative care QOL ascites symptom relief use validated survey instrument propose .</brief_summary>
	<brief_title>Palliative Care Outcomes Management Malignant Ascites Interventional Radiology</brief_title>
	<detailed_description />
	<mesh_term>Ascites</mesh_term>
	<criteria>Refractory malignant ascites define ascites require one paracentesis control patient symptom despite medical therapy diuretic a. peritoneal fluid cytology positive malignant cell OR Known malignancy image finding peritoneal carcinomatosis . Eastern Cooperative Oncology Group ( ECOG ) performance score 3 Age great equal 18 Capable give informed consent Life expectancy le one month Coagulopathy define international normalized ration ( INR ) &gt; 2 correct fresh frozen plasma Platelet count &lt; 50,000/microliter , correct platelet transfusion Active skin infection sit PVS would insert Presence infectious peritonitis bacteremia Neutropenia American Heart Association Class D congestive heart failure ( ie New York Heart Association Class IV ) Stage 5 CKD ( ie GFR &lt; 15 mL/min ) Severe hypoalbuminemia define &lt; 2.2 g/dL Loculated hemorrhagic ascites History bleed gastroesophageal varix Inability provide inform consent Unable participate neuropsychological test / questionnaire Pregnant nursing woman Anasarca</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Adult patient refractory malignant ascites secondary GU GI malignancy .</keyword>
</DOC>